Malignant Neoplasms of Lip Oral Cavity and Pharynx Recruiting Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0081505 (Malignant Neoplasms of Lip Oral Cavity and Pharynx)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03093909Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesTreatment